Seven genomic clones for mouse aggrecan core protein have been isolated including 3 kb of 5'-and 7 kb of 3'-flanking sequences. All exon sequences and their intron boundary sequences in these clones were identified and mapped by DNA sequencing. The gene spans at least 61 kb and contains 18 exons. Exon 1 encodes 5'-untranslated sequence and exon 2 contains a translation start codon, methionine. [4, 9, 10] and a partial one for mouse [11] which provide a structural model for aggrecan (for review, see [12] ). Aggrecan has three globular domains (GI, G2, G3), and two glycosaminoglycan attachment domains (KS and CS domains) located between G2 and G3. The two globular domains, GI and G2, comprise the N-terminus of the proteoglycan, while G3 makes up the C-terminus. GI has hyaluronic acid-binding activity and interacts with link protein. G2 is similar to both GI and link
INTRODUCTION
Aggrecan, a large aggregating proteoglycan, is one of the major structural constituents of cartilage. Aggrecan forms aggregates with hyaluronic acid. Link protein, a small glycoprotein which shares structural similarity with the N-terminal region of aggrecan, stabilizes the aggregates by interacting with both hyaluronic acid and aggrecan. The aggregates have a unique gellike property and function to resist compression and deformation (for review, see [1, 2] ). A deficiency of aggrecan has been described in cartilage of cmd(cartilage matrix deficiency) mice which are characterized by a cleft palate and short trunk, limbs and snout [3] . Similar defects are also found in chick nanomelia [4] .
Aggrecan consists of a protein core of approximately 220000-Mr which is extensively modified by covalently attached glycosaminoglycan side-chains and oligosaccharides. Biochemical studies have demonstrated many of the properties of this proteoglycan, including its binding to hyaluronic acid via an Nterminal globular region [5] and its extensive modification with chondroitin sulphate (CS) (up to 100 chains per monomer), keratan sulphate (KS) and other oligosaccharides [6] . cDNA cloning and sequencing studies have yielded a complete deduced primary structure for aggrecan from various species such as rat [7] , human [8] , chicken [4, 9, 10] and a partial one for mouse [11] which provide a structural model for aggrecan (for review, see [12] ). Aggrecan has three globular domains (GI, G2, G3), and two glycosaminoglycan attachment domains (KS and CS domains) located between G2 and G3. The two globular domains, GI and G2, comprise the N-terminus of the proteoglycan, while G3 makes up the C-terminus. GI has hyaluronic acid-binding activity and interacts with link protein. G2 is similar to both GI and link domains and subdomains, the sequence identity and the organization of exons encoding the subdomains B and B' of GI and G2 domains revealed a strong similarity of mouse aggrecan to both human versican and rat neurocan. Primer extension analysis identified four transcription start sites which are close together. The promoter sequence showed high G/C content (65 %) and contained several consensus binding motifs for transcription factors including Sp-1 and the glucocorticoid receptor. There are stretches of sequences similar to the promoter region of both the type-II collagen and link protein genes. These sequences may be important for cartilage gene expression.
protein, but its function is still unknown. G3 is a complex structure containing epidermal growth factor (EGF)-like, lectinlike and complement regulatory protein (CRP)-like domains.
The CS domain provides a number of attachment sites for CS, which enables retention of water in cartilage tissue. A short proline-rich sequence proximal to the CS domain has been shown to be the region most densely substituted with KS and is designated the KS domain. Similar domain structures are found in other proteoglycans such as versican [13, 14] and neurocan [15, 16] . Whereas cDNA data are available from different species, only partial structures of the aggrecan gene have been reported for rat [17] and chicken [18] .
In the present study, we isolated the mouse aggrecan gene from genomic libraries and determined exon sequences and exon-intron junctions. We also identified the transcription start sites by primer extension and characterized the promoter region of the aggrecan gene by DNA sequencing. This information will be useful for the study of the regulation of the aggrecan gene and of the function of aggrecan in development, especially using a transgenic mouse model.
MATERIALS AND METHODS

Genomic libraries
Two mouse genomic libraries, 129 SvJ in the A Fix II vector (Stratagene, La Jolla, CA, U.S.A.), and Balb/c in the EMBL3/ SP6/T7 vector (Clontech, Palo Alto, CA, U.S.A.) were screened with 32P-labelled mouse cDNA (pMAG8-115) [19] and rat cDNA [7] for aggrecan. The hybridization was performed in 6 x SSC §To whom correspondence should be addressed.
The nucleotide sequence reported in this paper has been submitted to the GenBank1/EMBL Data Bank with accession number U22901.
(SSC: 0. 15 M NaCl/0.0 1 5 M sodium citrate)/10 x Denhardt's solution/0.1 % SDS/100 ,tg/ml denatured salmon sperm DNA at 62°C overnight. The filters were washed twice in 2 x SSC/ 0.1 0% SDS at room temperature for 5 min, and in 0.1 x SSC/0. 1 % SDS at 62°C for the mouse probe or at room temperature for the rat probe, respectively, for 20 min twice. Positive phage clones were re-screened until pure and grown in liquid culture. Phage were purified by CsCl density gradient and DNA was extracted as previously described [20] . Restriction sites of these phage DNA were mapped by partial digestion with various restriction enzymes and by Southern hybridization with oligonucleotides as probes using Flash Non-radioactive Gene Mapping Kit (Stratagene).
DNA sequencing
For sequencing purposes, Southern blots of restriction enzyme digests of genomic clones were hybridized with cDNA probes and positive DNA fragments were subcloned into pBluescript II SK(-). In addition to oligonucleotide primers corresponding to the T3 and T7 recognition sites of the vector, 90 specific synthetic oligonucleotides were prepared and used as sequencing primers. 
Primer extension
The start site of transcription of the mouse aggrecan gene was analysed by primer extension. Total RNA was isolated from the sternal cartilage of newborn mice using the guanidium isothiocyanate method [21] . A specific oligonucleotide (5'-GAGAGAGAGTGAGGGACCTTGAGCCGTTCC-3') labelled with [y-32P]ATP at the 5'-end and 50 ,tg of total RNA were annealed and cDNA was extended by reverse transcriptase (M-MLV, Stratagene, La Jolla, CA, U.S.A. Figure 2) . The sequences at the intron-exon boundaries are in agreement with general consensus splice sequences [22] Table 2 . The overall nucleotide identity of the coding sequence between mouse and rat is 92.7 %, between mouse and human 75.9%, and between mouse and chicken 65.30%. The differences occur most frequently in the third positions. Overall amino acid identities of aggrecan core protein are 95.0 % for mouse and rat, 85.9 % for mouse and human and 67.9 % for mouse and chicken. The conservation of nucleotide and amino acid sequences varies, however, between the different domains ( Table 2 ). Significant correspondence between exon and structural domains is observed in the aggrecan gene and these features are described in detail below.
Signal peptide and N-terminal globular domains Gl and G2
The first methionine codon is followed by a presumptive signal peptide of 18 amino acids with 100 % and 75 % sequence identity to rat and human molecules respectively. The two N-terminal globular domains, GI and G2, show disulphide-bonded structural motifs. GI consists of three loop-like subdomains, loops A, B and B', whose structure is similar to link protein. The B and B' loops form a tandem homologous repeat, a critical structure for hyaluronic acid-binding activity [9] . The A loop shares structural similarity with an immunoglobulin fold and interacts with the A loop of link protein, which stabilizes the interaction of aggrecan and hyaluronic acid [23] . G2 does not have an A subdomain and consists of B and B' subdomains. G2 lacks hyaluronic acidbinding activity [5] . GI and G2 are highly conserved among species in both nucleotide and protein sequences (Table 2 ).
In particular, each subdomain of the mouse GI domain shows 96-100 %/o sequence similarity to that of rat and human molecules.
Similar structural motifs occur in other hyaluronic acid-binding proteins such as human versican [13, 14] , rat neurocan [15, 16] , and the lymphocyte homing receptor (CDw44 [24] ). The GI (Figure 3b ). Ser-Gly repeat sequences. Studies on CS-attachment sites using xylosyl activity of peptides suggested that the putative CS-recognition sequence is S-G-X-G [32] . However, there are only four S-G-X-G sequences in the mouse CS domain. Partial proteolytic digestion followed by HF deglycosylation of chick aggrecan demonstrated the CS-attachment sequence, (D,E)-X-S-G [33] . The mouse and rat CS domain contains 45 repeats of the tetrapeptide sequence. Together with the data that rat chondrosarcoma aggrecan has 80-100 CS chains [6] , this indicates that (D,E)-X-S-G may be the candidate for the CS-recognition site rather than S-G-X-G, although some other sequences may also be involved in CS attachment. [18] . According to previous reports [11, 18] , the exon for EGF2 should be located at the region approximately 2. packed within a 3.6 kb region. A similar gene structure for this domain is observed in chicken. The intron-exon boundaries are also conserved between the two species. The lectin-like domain is most similar to C-type carbohydrate-recognition domains (CRDs). As suggested [35, 36] , the lectin-like subdomain of aggrecan can be categorized into groups encoded by three separate exons, such as the asialoglycoprotein receptor, CD23 and the Kupffer cell receptor. Versican and neurocan also contain similar structural motifs at the C-termini.
Transcription start site and promoter sequence Primer extension revealed four transcription start sites which are clustered within 70 bp (Figure 4) . The positions of the transcription start are different from those of the rat aggrecan gene, although the gene structure is quite similar (Y. Yamada, unpublished work). Numbering the most upstream site as + 1, the G + C content within the 523 bp upstream sequence exceeds 65 %, similar to the promoter region of both the rat link protein and type-II collagen genes. Within the first 523 bp of the upstream sequence (Figure 4b) , there was no TATAA sequence. Two glucocorticoid receptor-binding sequences (TGTTCT/C) and one GGGCGG sequence (Sp-1 site) are located at -517 to -512, -380 to -375, and -426 to -421 respectively. There are several homologous direct repeat sequences including sequences between -317 to -308 and -274 to -285, and between -226 to -212 and -178 to -202. In addition, a region between -54 and -111 shows sequence identity to a sequence of the promoter (-103 to -132) of the rat type-TI collagen gene. This sequence is highly conserved in both the rat and mouse type-IT collagen genes [37] and is known to be important for type-II collagen gene promoter activity (Y. Yamada, unpublished work). Another stretch of sequence from -287 to -259 shows sequence similarity to a sequence of the promoter (-82 to -60) of rat link protein. These sequences may play a role in cartilagespecific gene expression.
Elucidation of the aggrecan gene structure will be useful in the study of the transcriptional regulation of the gene in development and pathological states. In addition, it will facilitate a better understanding of the function of aggrecan in vivo. Recently we have identified a 7 bp deletion in exon 5 of the aggrecan gene of cmd mice [19] . The mutation occurs at the B subdomain of the GI domain and leads to a termination codon within exon 6, resulting in a potentially truncated polypeptide of 36000-Mr. Although heterozygous cmd mice show a normal phenotype, the homozygous mice die soon after birth due to respiratory failure. It would be interesting to examine whether cmd mice could be rescued by introducing the normal aggrecan gene. It is also conceivable to study the function of an individual domain of aggrecan using transgenic mice models in normal and/or cmd mice.
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